One or more embodiments of the invention are directed to methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans. The methods comprise the step of administering to the patients a composition comprising a therapeutically effective amount of an extract from pomegranate.


> Morinda Citrifolia L. Based Formulations for Inhibiting Matrix Metalloproteinase Enzymes

~ 00368